U.S. Food and Drug Administration • Center for Drug Evaluation and Research
CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

CDER ArchivesSpecific AudiencesCDER CalendarRegulatory InformationDrug InformationAbout CDERSide Navigational Buttons

Office of Generic Drugs
ANDAs Tentative Approvals - July 2000
 

1

 . 75-289 NIFEDIPINE BIOVAIL LABORATORIES INC.

7/24/00

EXTENDED-RELEASE TABLETS,

USP 30 MG 60 MG

2

 . 75-536 DOXAZOSIN MESYLATE NOVOPHARM LIMITED

7/24/00

TABLETS 1 MG (BASE) 2 MG

(BASE) 4 MG (BASE) 8 MG (BASE)

3

 . 75-598 MINOXIDIL TOPICAL L. PERRIGO COMPANY

7/24/00

SOLUTION, USP (FOR MEN) 5%

4

 . 75-453 DOXAZOSIN MESYLATE ZENITH GOLDLINE

7/26/00

TABLETS 1 MG (BASE) 2 MG PHARMACEUTICALS, INC.

(BASE) 4 MG (BASE) 8 MG (BASE)

5

 . 75-580 DOXAZOSIN MESYLATE TORPHARM

7/26/00

TABLETS 1 MG (BASE) 2 MG

(BASE) 4 MG (BASE) 8 MG (BASE)

6

 . 75-718 FAMOTIDINE TABLETS, USP 20 CHEMINOR DRUGS LIMITED

7/27/00

MG 40 MG

 

totop.gif (1525 bytes) Back to Top   Back Back to Approvals

FDA/Center for Drug Evaluation and Research
Last Updated: September 10, 200125 Apr 2006 08:49:26 -0400
Originator: OGD
HTML by  PKS